Taurine and Bacterial Strain Compositions for MDRO Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The emergence of multidrug-resistant organisms (MDROs) poses a significant global health threat due to limited treatment options, primarily driven by the misuse and overuse of antibiotics, necessitating effective prevention and treatment strategies.
Innovation Solution
Compositions comprising purified bacterial strains from specific species, including Bacteroides, Clostridium, and Escherichia, combined with taurine, which are designed to suppress the replication and colonization of pathogenic organisms, including multidrug-resistant bacteria like carbapenem-resistant Enterobacteriaceae and extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat bacterial infections, then infection treatment effectiveness is improved, but antibiotic resistance development increases
Solution Approach 1:
The patent utilizes the concept of competitive exclusion by introducing beneficial bacterial strains that compete with pathogenic organisms for resources and colonization sites. This converts the harm of antibiotic resistance into a benefit by using natural microbial competition to suppress MDROs, thereby treating infections without contributing to further antibiotic resistance development.
Solution Approach 2:
The patent introduces beneficial bacterial strains as intermediary organisms that mediate the suppression of multidrug-resistant organisms. These intermediary bacteria produce bacteriocins and other antimicrobial substances that directly inhibit MDROs, providing an alternative mechanism to antibiotics for treating infections while avoiding resistance issues.
2Object-generated harmful factors
If antibiotic use is reduced to prevent resistance, then antibiotic resistance development is reduced, but treatment options for existing infections are limited
Solution Approach 1:
The patent describes compositions containing multiple bacterial strains that can target various types of multidrug-resistant organisms including VRE, CRE, and ESBL-producing Enterobacteriaceae. This multi-functional approach provides versatile treatment options for different MDRO infections while maintaining reduced antibiotic use, thereby addressing both the need to limit resistance development and the need for effective treatment alternatives.
3Reliability
If multiple bacterial strains are combined in compositions, then suppression of pathogenic organisms is improved, but composition complexity increases
Solution Approach 1:
The patent combines multiple purified bacterial strains into single compositions, merging the therapeutic effects of different strains that produce various bacteriocins and antimicrobial substances. This synergistic combination enhances suppression of diverse pathogenic organisms while the strains are formulated together in a unified composition that can be administered as a single product, managing complexity through integrated formulation.
Data Source
AI summary
Provided herein are compositions and methods for suppressing infection by pathogenic organisms. Also provided herein are compositions and methods for reducing or preventing colonization by pathogenic organisms and methods of treating infection by a pathogenic organism. Also provided herein are compositions comprising taurine and methods of using such compositions for suppressing infection by pathogenic organisms, preventing colonization by pathogenic organisms, and methods of treating infection pathogenic organisms.